Status:
WITHDRAWN
Gabapentin for Relief of Immediate Postoperative Pain
Lead Sponsor:
Indiana University
Conditions:
Postoperative Pain
Eligibility:
FEMALE
18+ years
Phase:
PHASE1
PHASE2
Brief Summary
The purpose of this study is to use gabapentin as an additional or alternative treatment for short term pain control following cesarean delivery in order to reduce the use of opioid pain medication an...
Detailed Description
This is a randomized, placebo controlled, double blind study. After consent, the subject will complete a Depression Screening to establish a baseline score. Within 2 hours following completion of a ce...
Eligibility Criteria
Inclusion
- Pregnant women at least 18 years of age
- Gestational age \> or = to 30 weeks
- Singleton gestation
- Women undergoing a non-emergent cesarean delivery
- Spinal anesthesia or combined spinal-epidural anesthesia utilized during cesarean
- Ability to undergo the informed consent process in English
Exclusion
- Vertical skin incision
- General anesthesia for cesarean
- History of major depression or postpartum depression requiring medication
- Chronic opiate use during pregnancy, defined as anyone who has taken an opioid or opioid replacement therapy in the 3 days prior to admission for delivery. This does not include opioids given for labor anesthesia.
- Magnesium sulfate treatment postpartum
- Preexisting fibromyalgia, chronic pain syndrome, or rheumatologic disorder
Key Trial Info
Start Date :
July 2 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2020
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03750773
Start Date
July 2 2019
End Date
April 1 2020
Last Update
July 29 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.